Search research articles
Contact Us
Filters
Showing results (21-30 of 57) with videos related to
Page
of 6
Sort By:
Cell Death & Disease
|
September 9, 2016
Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents
Olaf Klingbeil, Ralf Lesche, Kathy A Gelato, et al.
Cancer Cell International
|
January 20, 2012
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
Friedrich G Kapp, Anette Sommer, Thomas Kiefer, et al.
Molecular and Cellular Endocrinology
|
December 22, 2005
The ubiquitin-specific protease USP10 modulates androgen receptor function
Hortensia Faus, Hellmuth-Alexander Meyer, Martina Huber, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H O'Donovan, Clara Lemos, et al.
Epigenomics
|
June 17, 2015
Targeting BET bromodomains for cancer treatment
Marie Jung, Kathy A Gelato, Amaury Fernández-Montalván, et al.
Molecular Reproduction and Development
|
April 28, 2004
Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene
Bernard Haendler, Hiroshi Yamanouchi, Bruce A Lessey, et al.
Biochemistry
|
January 17, 2025
Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis
Weronika Trun, Amaury Fernández-Montalván, Yong-Jiang Cao, et al.
Endocrinology
|
July 5, 2008
Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-á-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2
Zhi-Yuan Wu, Kun Chen, Bernard Haendler, et al.
Molecular Oncology
|
April 26, 2020
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, et al.
International Journal of Oncology
|
September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models
Tomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 57) with videos related to
Sort By:
Page
of 6
Cell Death & Disease
|
September 9, 2016
Inhibition of BET bromodomain-dependent XIAP and FLIP expression sensitizes KRAS-mutated NSCLC to pro-apoptotic agents
Olaf Klingbeil, Ralf Lesche, Kathy A Gelato, et al.
Cancer Cell International
|
January 20, 2012
5-alpha-reductase type I (SRD5A1) is up-regulated in non-small cell lung cancer but does not impact proliferation, cell cycle distribution or apoptosis
Friedrich G Kapp, Anette Sommer, Thomas Kiefer, et al.
Molecular and Cellular Endocrinology
|
December 22, 2005
The ubiquitin-specific protease USP10 modulates androgen receptor function
Hortensia Faus, Hellmuth-Alexander Meyer, Martina Huber, et al.
International Journal of Molecular Sciences
|
February 11, 2023
Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
Fabio Raith, Daniel H O'Donovan, Clara Lemos, et al.
Epigenomics
|
June 17, 2015
Targeting BET bromodomains for cancer treatment
Marie Jung, Kathy A Gelato, Amaury Fernández-Montalván, et al.
Molecular Reproduction and Development
|
April 28, 2004
Cycle-dependent endometrial expression and hormonal regulation of the fibulin-1 gene
Bernard Haendler, Hiroshi Yamanouchi, Bruce A Lessey, et al.
Biochemistry
|
January 17, 2025
Inhibition of EphB4 Receptor Signaling by Ephrin-B2-Competitive and Non-Competitive DARPins Prevents Angiogenesis
Weronika Trun, Amaury Fernández-Montalván, Yong-Jiang Cao, et al.
Endocrinology
|
July 5, 2008
Stimulation of N-terminal truncated isoform of androgen receptor stabilizes human ether-á-go-go-related gene-encoded potassium channel protein via activation of extracellular signal regulated kinase 1/2
Zhi-Yuan Wu, Kun Chen, Bernard Haendler, et al.
Molecular Oncology
|
April 26, 2020
Darolutamide antagonizes androgen signaling by blocking enhancer and super-enhancer activation
Simon J Baumgart, Ekaterina Nevedomskaya, Ralf Lesche, et al.
International Journal of Oncology
|
September 3, 2009
Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models
Tomke Ute Bracker, Anette Sommer, Iduna Fichtner, et al.
Page
of 6